Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery
- 1 April 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 318 (4), G661-G672
- https://doi.org/10.1152/ajpgi.00265.2019
Abstract
Postprandial gut hormone responses change after Roux-en-Y gastric bypass (RYGB), but little is known about the importance of the different macronutrients for this. We investigate the impact of glucose, protein and fat (with and without pancreas lipase inhibition) on plasma responses of gut and pancreas hormones, bile acids and FGF-21 after Roux-en-Y gastric bypass (RYGB) and in matched non-operated control subjects. In single-blinded, randomized, cross-over study ten RYGB operated and eight healthy weight-matched control subjects were administered four different 4-hour isocaloric (200 kcal) liquid meal-tests containing >90E% of either glucose, protein (whey protein) or fat (butter with and without orlistat®). The primary outcome was GLP-1 secretion (area under the curve above baseline). Secondary outcomes included responses of PYY, GIP, CCK, glicentin, neurotensin, insulin, glucagon, bile acids and FGF 21. In the RYGB group the responses of GLP-1, GIP, glicentin, FGF-21 and C-peptide were increased after glucose compared with the other meals. The neurotensin and bile acids responses were greater after fat, while the glucagon and CCK responses were greater after protein ingestion. Furthermore, compared with control subjects, RYGB subjects had greater responses of total PYY after glucose, glucagon after glucose and fat, glicentin after glucose and protein, and GLP-1 and neurotensin after all meals, while GIP and CCK responses were lower after fat. Orlistat® reduced all hormone responses to fat ingestion. In conclusion, after RYGB glucose is a more potent stimulator of most gut hormones, especially for the marked increased secretion of GLP-1 compared with fat and protein.Keywords
Funding Information
- EC | European Research Council (695069)
- Novo Nordisk Fundation (NNF160C0021498)
- Novo Nordisk Foundation (NNF150C0017188)
- Research Foundation of the Capital Region of Denmark
- Internal Research at Hvidovre Hospital
This publication has 68 references indexed in Scilit:
- Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individualsDiabetologia, 2013
- Roux‐en‐Y gastric bypass surgery increases number but not density of CCK‐, GLP‐1‐, 5‐HT‐, and neurotensin‐expressing enteroendocrine cells in ratsNeurogastroenterology & Motility, 2012
- Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose toleranceAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- Metabolic and Hormonal Changes After Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: a Randomized, Prospective TrialObesity Surgery, 2012
- Gastrojejunal Stoma Diameter Predicts Weight Regain After Roux-en-Y Gastric BypassClinical Gastroenterology and Hepatology, 2011
- Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 SecretionDiabetes Care, 2009
- Acyl and Total Ghrelin Are Suppressed Strongly by Ingested Proteins, Weakly by Lipids, and Biphasically by CarbohydratesJournal of Clinical Endocrinology & Metabolism, 2008
- Effects of Bariatric Surgery on Mortality in Swedish Obese SubjectsThe New England Journal of Medicine, 2007
- Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studiesInternational Journal of Obesity, 2000
- Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesityInternational Journal of Obesity, 1997